Business & Finance
Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications
Key Points
The Danish company Novo says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs.
The Danish company Novo says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs.
[Image text:] novo nordisk